BIAF
bioAffinity Technologies, Inc. · Healthcare
4.09
2.15%(-0.09)
Close4.13
0.98%(+0.04)
After HoursLast Updated: — ET
52W L: $0.6952W H: $21.90
$4.07
CHG+3.04 (+295.15%)
H$5.38
L$1.00
VOL401M
BIAF (1h)
bioAffinity Technologies, Inc. · Healthcare
SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--CyPath Lung, bioAffinity Technologies' noninvasive test for lung cancer, will be featured at the Cleveland Clinic's annual lung cancer symposium.
SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #CyPathLung--bioAffinity Technologies' CyPath Lung Sales Surged 146% Year-Over-Year in Q1 2026, gaining traction in the U.S. addressable market of $3.58 billion.
SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies will host a webinar on April 8 with leading pulmonologists who will share their clinical experience with CyPath Lung.
bioAffinity Technologies (NASDAQ: BIAF - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of ($2.70) per share and revenue of $1.5530 million for the quarter. Parties may review the information on the company's upcoming Q4 2025 earning report
SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in physician decision-making and patient outcome.
bioAffinity Technologies Inc (NASDAQ: BIAF) stock falls in Monday premarket. Investors weigh 2025 revenue declines against surging CyPath Lung sales.
Rios Roberto
director
0 SH @ $0.00
2025-08-12
Oppenheimer John J.
director:
0 SH @ $0.00
2025-08-12
Reveles Xavier Trinidad
officer: Chief Operating Officer
21,604 SH @ $0.00
2025-01-10
GIRGENTI STEVEN
director, officer: Executive Chairman
14,814 SH @ $0.00
2025-01-10
Zannes Maria
director, officer: President & CEO
37,037 SH @ $0.00
2025-01-10
Edwards James Michael
officer: VP and CFO
6,172 SH @ $0.00
2025-01-10
Zannes Timothy P
officer: Secretary, EVP, Gen. Counsel
8,641 SH @ $0.00
2025-01-10
Edwards James Michael
officer: VP and CFO
100,000 SH @ $0.00
2024-11-05